Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.
Proliferation of MCF-7 and MDA-MB-231 inhibited by both calcitriol and COX2 inhibitor celecoxib.
»
10/31/17
Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer.
Therapeutic targeting of biomolecules may be improved by nanotechnology strategies.
»
10/21/17
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis
Mean circularity showed association with time to distant metastasis.
»
02/05/18
miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression
After transfection of cells with miR-29b inhibitor, mRNA expression increased in DU145 cells.
»
02/05/18
Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells
Nischarin-expressing cells have reduced ability to attach the ECM.
»
02/07/18
Smoking and prostate cancer: a life course analysis
Male smokers who had initial period of low intensity, followed by period of more intensity, associated with higher poorly differentiated PC.
»
02/07/18
Long-term outcome of a single intervention Population based Prostate Cancer Screening Study.
Incidence of prostate cancer remained higher in the screened population.
»
01/20/18
Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.
Increased infiltration of regulatory T cells into core tumor regions independent predictor of worse overall survival in NSCLC.
»
12/11/17
Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
Three types of screening options available.
»
12/29/17
PBX3 is part of an EMT regulatory network and indicates poor outcome in colorectal cancer.
PBX3 was expressed in tumor cells with high WNT activity.
»
01/25/18
< Prev
Next >